CRIS
Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1
Browse
5 results
Search Results
Now showing 1 - 5 of 5
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome(2023) ;Erik Boot ;Sólveig Óskarsdóttir ;Joanne C.Y. Loo ;Terrence Blaine CrowleyAni Orchanian-CheffScopus© Citations 76 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome(2023) ;Sólveig Óskarsdóttir ;Erik Boot ;Terrence Blaine Crowley ;Joanne C.Y. LooJill M. ArganbrightScopus© Citations 50 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion(2020) ;Isabelle Cleynen ;Worrawat Engchuan ;Matthew S. Hestand ;Tracy HeungAaron M. HollemanScopus© Citations 98 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, A normative chart for cognitive development in a genetically selected population(2021) ;Ania M. Fiksinski ;Carrie E. Bearden ;Anne S. Bassett ;René S. KahnJanneke R. Zinkstok15Scopus© Citations 19 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the GPR98 Locus on 5q14.3(2017) ;Tingwei Guo; ;Donna M. McDonald McGinn ;Jonathan H. ChungHiroko Nomaru<jats:sec> <jats:title>Background—</jats:title> <jats:p>The 22q11.2 deletion syndrome (22q11.2DS; DiGeorge syndrome/velocardiofacial syndrome) occurs in 1 of 4000 live births, and 60% to 70% of affected individuals have congenital heart disease, ranging from mild to severe. In our cohort of 1472 subjects with 22q11.2DS, a total of 62% (n=906) have congenital heart disease and 36% (n=326) of these have tetralogy of Fallot (TOF), comprising the largest subset of severe congenital heart disease in the cohort.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and Results—</jats:title> <jats:p> To identify common genetic variants associated with TOF in individuals with 22q11.2DS, we performed a genome-wide association study using Affymetrix 6.0 array and imputed genotype data. In our cohort, TOF was significantly associated with a genotyped single-nucleotide polymorphism (rs12519770, <jats:italic>P</jats:italic> =2.98×10 <jats:sup>−</jats:sup> <jats:sup>8</jats:sup> ) in an intron of the adhesion <jats:italic>GPR98</jats:italic> (G-protein–coupled receptor V1) gene on chromosome 5q14.3. There was also suggestive evidence of association between TOF and several additional single-nucleotide polymorphisms in this region. Some genome-wide significant loci in introns or noncoding regions could affect regulation of genes nearby or at a distance. On the basis of this possibility, we examined existing Hi-C chromatin conformation data to identify genes that might be under shared transcriptional regulation within the region on 5q14.3. There are 6 genes in a topologically associated domain of chromatin with <jats:italic>GPR98</jats:italic> , including <jats:italic>MEF2C</jats:italic> (Myocyte-specific enhancer factor 2C). <jats:italic>MEF2C</jats:italic> is the only gene that is known to affect heart development in mammals and might be of interest with respect to 22q11.2DS. </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p>In conclusion, common variants may contribute to TOF in 22q11.2DS and may function in cardiac outflow tract development.</jats:p> </jats:sec>Scopus© Citations 21 4